The FDA has recalled over two million Dexcom blood glucose monitors, including G6 and G7 receivers, due to alarm failures that could prevent users from receiving critical health warnings. This malfunction raises the risk of severe health issues, such as seizures and fainting, for millions of diabetes patients. Class I designation indicates the risk of serious harm or death. Despite Dexcom's earlier statements regarding limited issues, global reports indicate significant health incidents linked to the defect, drawing attention to the potential dangers these faulty devices pose to public health.
An urgent recall has been issued for over two million Dexcom blood glucose monitors, as faulty alarms can escalate the risk of severe health issues for diabetes patients.
According to the FDA, the faulty devices may prevent audible alerts for high or low blood sugar, resulting in increased danger of hypoglycemia or hyperglycemia.
Collection
[
|
...
]